Fed. Circ. Won't Rehear Ruling That Axed 4 OxyContin Patents

By Matthew Bultman
May 4, 2016, 5:47 PM EDT

The Federal Circuit declined Wednesday to review a decision that four patents on Purdue Pharma LP's painkiller OxyContin are invalid, cementing a victory for four generics makers that are planning their...

Already a subscriber? Click here to view full article